content

Medivant Launches Pharma Mfg. Ops in US

A new U.S.-based pharmaceutical manufacturer, Tailstorm Health, Inc., DBA Medivant Healthcare, will begin to roll out sterile single dose liquid injectable medications on the...

BARDA Funds Development of Tangen Biosciences Multi-Target Platform

The U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) has awarded Tangen the Second Option of a contract...

Catalent Partners with Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19

Catalent, a global leader in clinical supply services, welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its...

Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received...

Digital Science reports that just 10% of global research output relates to the UN’s Sustainable Development Goals

Digital Science, a leading technology company serving emergent needs across the research sector, has released a report highlighting the growth in research around the...

Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program

Pfizer Inc. and BioNTech SE announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the...

Rescheduled CPhI South East Asia to now take place in November 2020

CPhI South East Asia – organised by Informa Markets – has postponed its rescheduled event to November 4-6, 2020 to provide more time for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read